Holen Sie sich die Stockscreener-App
4.37
1.13%
-0.05
Handel nachbörslich:
4.37
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Adaptive Biotechnologies (FRA:1HM) Operating Margin % : -70.27% (As of Sep. 2024) - GuruFocus.com
Tarsus Pharmaceuticals (NASDAQ:TARS) versus Adaptive Biotechnologies (NASDAQ:ADPT) Financial Survey - Defense World
Adaptive Biotechnologies' CFO Kyle Piskel sells $1,235 in shares By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies' CFO Kyle Piskel sells $1,235 in shares - Investing.com India
Adaptive Biotechnologies Corp: Is ADPT Stock Worth Buying? - Stocks Register
William Blair Has Bullish Forecast for ADPT FY2024 Earnings - MarketBeat
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Sees Significant Decrease in Short Interest - MarketBeat
Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know - Yahoo Finance
Rubric Capital Management LP's Strategic Acquisition in Adaptive Biotechnologies Corp - GuruFocus.com
Matrix Capital Management Reduces Stake in Adaptive Biotechnologies Corp - GuruFocus.com
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 12.7% Following Analyst Upgrade - Defense World
Adaptive Biotechnologies (NASDAQ:ADPT) Trading 12.7% Higher After Analyst Upgrade - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $7.00 - MarketBeat
ADPT (Adaptive Biotechnologies) Cash From Other Investing A - GuruFocus.com
Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2024 Earnings Call Transcript - Insider Monkey
Nikko Asset Management Americas, Inc. Expands Stake in Adaptive Biotechnologies Corp - GuruFocus.com
Earnings call: Adaptive Biotechnologies posts robust MRD revenue growth - Investing.com
ARK Investment Management LLC Buys 189,134 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - MarketBeat
Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highl - GuruFocus.com
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ... - Yahoo Finance
ADPT stock touches 52-week high at $5.81 amid biotech rally By Investing.com - Investing.com South Africa
ADPT stock touches 52-week high at $5.81 amid biotech rally - Investing.com Canada
Adaptive Biotechnologies earnings beat by $0.07, revenue topped estimates - Investing.com
Adaptive Biotechnologies : Q3 2024 Earnings Presentation - Marketscreener.com
Adaptive Biotechnologies: Q3 Earnings Snapshot - CT Insider
ADPTAdaptive Biotechnologies Corporation Latest Stock News & Market Updates - StockTitan
Adaptive Biotechnologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings: Revenue S - GuruFocus.com
Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results - Yahoo Finance
Medicare expands coverage for MRD test in lymphoma - Investing.com
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma - Yahoo Finance
ADPT (Adaptive Biotechnologies) Total Stockholders Equity : $241.6 Mil (As of Jun. 2024) - GuruFocus.com
Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result - GuruFocus.com
Sumitomo Mitsui Trust Group's Strategic Acquisition in Adaptive Biotechnologies - GuruFocus.com
Vanguard Group Inc's Strategic Acquisition in Adaptive Biotechno - GuruFocus.com
November 2024's Top US Penny Stocks With Growth Potential - Yahoo Finance
ADPT (Adaptive Biotechnologies) Cyclically Adjusted Book pe - GuruFocus.com
Adaptive Biotechnologies (ADPT) Scheduled to Post Earnings on Thursday - MarketBeat
Cancer Immunotherapy Global Market 2024 To Reach $175.39Billion By 2028 At Rate Of 12.1% - EIN News
Cancer Immunotherapy Global Market 2024 To Reach $175.39 Billion By 2028 At Rate Of 12.1% - EIN News
ADPT (Adaptive Biotechnologies) PE Ratio : At Loss (As of Oct. 30, 2024) - GuruFocus.com
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Receives $7.00 Consensus Price Target from Analysts - MarketBeat
Perhaps timely catching Adaptive Biotechnologies Corp (ADPT) would be a good idea - SETE News
Adaptive Biotechnologies Corp [ADPT] Stock sold by Insider Taylor Stacy L for $0.12 million - Knox Daily
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap UpStill a Buy? - MarketBeat
Stock Surge: Adaptive Biotechnologies Corp (ADPT) Closes at 4.94, Marking a 0.61 Increase/Decrease - The Dwinnex
Should investors be concerned about Adaptive Biotechnologies Corp (ADPT)? - US Post News
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap DownTime to Sell? - MarketBeat
Insider Selling: Taylor Stacy L, Adaptive Biotechnologies Corp [ADPT] SVP and General Counsel divested 26,922 shares – Knox Daily - Knox Daily
ADPT’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):